IRIS Accounts Production v23.3.0.418 13876140 director 27.1.22 31.1.23 31.1.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure138761402022-01-26138761402023-01-31138761402022-01-272023-01-31138761402022-01-2613876140ns16:EnglandWales2022-01-272023-01-3113876140ns15:PoundSterling2022-01-272023-01-3113876140ns11:Director12022-01-272023-01-3113876140ns11:PrivateLimitedCompanyLtd2022-01-272023-01-3113876140ns11:SmallEntities2022-01-272023-01-3113876140ns11:AuditExempt-NoAccountantsReport2022-01-272023-01-3113876140ns11:SmallCompaniesRegimeForDirectorsReport2022-01-272023-01-3113876140ns11:SmallCompaniesRegimeForAccounts2022-01-272023-01-3113876140ns11:FullAccounts2022-01-272023-01-3113876140ns6:CurrentFinancialInstruments2023-01-3113876140ns6:ShareCapital2023-01-3113876140ns6:SharePremium2023-01-3113876140ns6:RetainedEarningsAccumulatedLosses2023-01-3113876140ns11:RegisteredOffice2022-01-272023-01-3113876140ns6:ComputerEquipment2022-01-272023-01-3113876140ns6:PlantMachinery2022-01-272023-01-3113876140ns6:PlantMachinery2023-01-3113876140ns6:WithinOneYearns6:CurrentFinancialInstruments2023-01-31
REGISTERED NUMBER: 13876140 (England and Wales)


















Unaudited Financial Statements

for the Period 27 January 2022 to 31 January 2023

for

StockRx Limited

StockRx Limited (Registered number: 13876140)






Contents of the Financial Statements
for the Period 27 January 2022 to 31 January 2023




Page

Balance Sheet 1

Notes to the Financial Statements 2


StockRx Limited (Registered number: 13876140)

Balance Sheet
31 January 2023

Notes £   
FIXED ASSETS
Tangible assets 4 1,387

CURRENT ASSETS
Debtors 5 2,866
Cash at bank 401,217
404,083
CREDITORS
Amounts falling due within one year 6 (10,653 )
NET CURRENT ASSETS 393,430
TOTAL ASSETS LESS CURRENT
LIABILITIES

394,817

CAPITAL AND RESERVES
Called up share capital 1
Share premium 749,918
Retained earnings (355,102 )
394,817

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 January 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 January 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 October 2023 and were signed by:





W A Granger-Cohet - Director


StockRx Limited (Registered number: 13876140)

Notes to the Financial Statements
for the Period 27 January 2022 to 31 January 2023

1. STATUTORY INFORMATION

StockRx Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 13876140

Registered office: Little Tufton House
3 Dean Trench Street
London
SW1P 3HB

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Computer equipment - Straight line over 3 years

Taxation
Taxation for the period comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

StockRx Limited (Registered number: 13876140)

Notes to the Financial Statements - continued
for the Period 27 January 2022 to 31 January 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
Additions 2,081
At 31 January 2023 2,081
DEPRECIATION
Charge for period 694
At 31 January 2023 694
NET BOOK VALUE
At 31 January 2023 1,387

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Other debtors 2,866

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 8,379
Other creditors 2,274
10,653